IPP Bureau
LG Chem enters Chinese osteoarthritis treatment market
By IPP Bureau - July 03, 2024
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Abbott and YRGCARE inaugurate new outreach centers in India
By IPP Bureau - July 02, 2024
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
By IPP Bureau - July 02, 2024
Imfinzi also recommended for patients with mismatch repair deficient disease
Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
By IPP Bureau - July 02, 2024
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
DKSH and Kimberly-Clark Partner to Launch Huggies Baby and Childcare Products in Cambodia
By IPP Bureau - July 02, 2024
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
Briefs: Family Care Hospitals, Laurus Labs and Bafna Pharmaceuticals
By IPP Bureau - June 30, 2024
Laurus Labs receives EIR from USFDA for API facilities
ONGC to enhance healthcare facilities at Baltal and Chandanwari in J&K
By IPP Bureau - June 30, 2024
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India
By IPP Bureau - June 29, 2024
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg
By IPP Bureau - June 29, 2024
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
HCG acquires 51% stake in Mahatma Gandhi Cancer Hospital and Research Institute, Vizag
By IPP Bureau - June 29, 2024
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Aurobindo Pharma’s subsidiary acquires Ace Laboratories, UK
By IPP Bureau - June 29, 2024
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Jubilant Ingrevia receives EIR from USFDA for Unit-1 at Bharuch
By IPP Bureau - June 28, 2024
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Eugia SEZ’s injectable facility gets EIR from USFDA
By IPP Bureau - June 28, 2024
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
